To validate a connection between TMPRSS11B-, BSG- and SLC16A1-driven cancer stemness clinically, tumor specimens from PDAC patients were analyzed by immunohistochemistry (Figure 8). The gene discussed is SLC16A1; the disease is neoplasm.